230 related articles for article (PubMed ID: 30121800)
1. Positive effects of single-daily high-dose mizoribine therapy after cyclophosphamide in young children with steroid-dependent nephrotic syndrome.
Mizutani A; Fujinaga S; Sakuraya K; Hirano D; Shimizu T
Clin Exp Nephrol; 2019 Feb; 23(2):244-250. PubMed ID: 30121800
[TBL] [Abstract][Full Text] [Related]
2. Assessment of factors associated with mizoribine responsiveness in children with steroid-dependent nephrotic syndrome.
Kondoh T; Ikezumi Y; Yokoi K; Nakajima Y; Matsumoto Y; Kaneko M; Hasegawa H; Yamada T; Kumagai N; Ito T; Yoshikawa T
Clin Exp Nephrol; 2019 Sep; 23(9):1154-1160. PubMed ID: 31187341
[TBL] [Abstract][Full Text] [Related]
3. Single daily high-dose mizoribine therapy for children with steroid-dependent nephrotic syndrome prior to cyclosporine administration.
Fujinaga S; Hirano D; Nishizaki N; Someya T; Ohtomo Y; Ohtsuka Y; Shimizu T; Kaneko K
Pediatr Nephrol; 2011 Mar; 26(3):479-83. PubMed ID: 21174219
[TBL] [Abstract][Full Text] [Related]
4. Predictors of Treatment Response and Long-Term Outcomes in Young Children with Steroid-Dependent Nephrotic Syndrome Treated with High-Dose Mizoribine as First-Line Steroid-Sparing Agent.
Fujinaga S; Endo S; Morishita T; Takemasa Y; Onuki Y; Sakuraya K; Hirano D
Tohoku J Exp Med; 2022 Jan; 256(1):85-91. PubMed ID: 35095030
[TBL] [Abstract][Full Text] [Related]
5. Maintenance therapy with single-daily, high-dose mizoribine after cyclophosphamide therapy for prepubertal boys with severe steroid-dependent nephrotic syndrome.
Fujinaga S; Endo A; Watanabe T; Hirano D; Ohtomo Y; Shimizu T; Kaneko K
Clin Nephrol; 2012 Sep; 78(3):251-2. PubMed ID: 22541687
[No Abstract] [Full Text] [Related]
6. Evaluation of mycophenolate mofetil or tacrolimus in children with steroid sensitive but frequently relapsing or steroid-dependent nephrotic syndrome.
Wang J; Mao J; Chen J; Fu H; Shen H; Zhu X; Liu A; Shu Q; Du L
Nephrology (Carlton); 2016 Jan; 21(1):21-7. PubMed ID: 26697959
[TBL] [Abstract][Full Text] [Related]
7. Study protocol: mycophenolate mofetil as maintenance therapy after rituximab treatment for childhood-onset, complicated, frequently-relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicenter double-blind, randomized, placebo-controlled trial (JSKDC07).
Horinouchi T; Sako M; Nakanishi K; Ishikura K; Ito S; Nakamura H; Oba MS; Nozu K; Iijima K
BMC Nephrol; 2018 Nov; 19(1):302. PubMed ID: 30382824
[TBL] [Abstract][Full Text] [Related]
8. High-dose mizoribine therapy for childhood-onset frequently relapsing steroid-dependent nephrotic syndrome with cyclosporin nephrotoxicity.
Ohtomo Y; Fujinaga S; Takada M; Murakami H; Akashi S; Shimizu T; Kaneko K; Yamashiro Y
Pediatr Nephrol; 2005 Dec; 20(12):1744-9. PubMed ID: 16133041
[TBL] [Abstract][Full Text] [Related]
9. Effect of single-dose oral mizoribine pulse therapy twice per week for frequently relapsing steroid-dependent nephrotic syndrome.
Fujieda M; Ishihara M; Morita T; Hayashi A; Okada S; Ohta T; Sakano T; Wakiguchi H
Clin Nephrol; 2012 Jul; 78(1):40-6. PubMed ID: 22732336
[TBL] [Abstract][Full Text] [Related]
10. Treatment course of steroid-dependent nephrotic syndrome: emphasized on treatment effect.
Chen SY; Wu CY; Tsai IJ; Tsau YK
Nephrology (Carlton); 2010 Apr; 15(3):336-9. PubMed ID: 20470303
[TBL] [Abstract][Full Text] [Related]
11. Should rituximab be administered before cyclophosphamide as a first-line steroid-sparing agent to young children with steroid-dependent nephrotic syndrome?
Fujinaga S; Mizutani A
Clin Exp Nephrol; 2020 Dec; 24(12):1187-1188. PubMed ID: 32728924
[No Abstract] [Full Text] [Related]
12. Risk factors for relapse and long-term outcome in steroid-dependent nephrotic syndrome treated with rituximab.
Kamei K; Ogura M; Sato M; Sako M; Iijima K; Ito S
Pediatr Nephrol; 2016 Jan; 31(1):89-95. PubMed ID: 26341251
[TBL] [Abstract][Full Text] [Related]
13. [Beneficial and adverse effects of high-dosage MZR therapy in the management of children with frequently relapsing nephrotic syndrome].
Goto M; Ikeda M; Hataya H; Ishikura K; Hamasaki Y; Honda M
Nihon Jinzo Gakkai Shi; 2006; 48(4):365-70. PubMed ID: 16780106
[TBL] [Abstract][Full Text] [Related]
14. Oral mizoribine pulse therapy for patients with steroid-resistant and frequently relapsing steroid-dependent nephrotic syndrome.
Kawasaki Y; Hosoya M; Kobayashi S; Ohara S; Onishi N; Takahashi A; Isome M; Suzuki H
Nephrol Dial Transplant; 2005 Oct; 20(10):2243-7. PubMed ID: 16030039
[TBL] [Abstract][Full Text] [Related]
15. [Immunosuppressive therapy for nephrotic syndrome and strategy for adverse side effects from that therapy].
Takeda Y; Tomino Y
Nihon Rinsho; 2004 Oct; 62(10):1875-9. PubMed ID: 15500133
[TBL] [Abstract][Full Text] [Related]
16. Study protocol: high-dose mizoribine with prednisolone therapy in short-term relapsing steroid-sensitive nephrotic syndrome to prevent frequent relapse (JSKDC05 trial).
Hama T; Nakanishi K; Ishikura K; Ito S; Nakamura H; Sako M; Saito-Oba M; Nozu K; Shima Y; Iijima K; Yoshikawa N;
BMC Nephrol; 2018 Sep; 19(1):223. PubMed ID: 30200895
[TBL] [Abstract][Full Text] [Related]
17. [Multicenter survey of diagnostic and therapeutic status in Chinese childhood patients with steroid-sensitive, relaping/steroid-dependent nephrotic syndrome].
Working Group For National Survey On Status Of Diagnosis And Treatment Of Childhood Renal Diseases
Zhonghua Er Ke Za Zhi; 2014 Mar; 52(3):194-200. PubMed ID: 24824389
[TBL] [Abstract][Full Text] [Related]
18. Mizoribine for the treatment of lupus nephritis in children and adolescents.
Tanaka H; Tsugawa K; Tsuruga K; Suzuki K; Nakahata T; Ito E; Waga S
Clin Nephrol; 2004 Dec; 62(6):412-7. PubMed ID: 15630899
[TBL] [Abstract][Full Text] [Related]
19. Mizoribine therapy combined with steroids and mizoribine blood concentration monitoring for idiopathic membranous nephropathy with steroid-resistant nephrotic syndrome.
Saito T; Iwano M; Matsumoto K; Mitarai T; Yokoyama H; Yorioka N; Nishi S; Yoshimura A; Sato H; Ogahara S; Sasatomi Y; Kataoka Y; Ueda S; Koyama A; Maruyama S; Nangaku M; Imai E; Matsuo S; Tomino Y;
Clin Exp Nephrol; 2017 Dec; 21(6):961-970. PubMed ID: 27783276
[TBL] [Abstract][Full Text] [Related]
20. Immunosuppressive therapy in children with primary nephrotic syndrome: single center experience, Karachi, Pakistan.
Moorani KN; Hotchandani HM; Zubair AM; Lohana NC; Veerwani NR
BMC Nephrol; 2019 Jul; 20(1):239. PubMed ID: 31269922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
